Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: A remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD)

Details

Language :

English

ISSN :

15455009

Volume :

57

Issue :

2

Database :

Complementary Index

Journal :

Pediatric Blood & Cancer

Publication Type :

Academic Journal

Accession number :

104646057

Full Text :

https://doi.org/10.1002/pbc.23004